The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
Authors
Keywords
-
Journal
Biomedicines
Volume 9, Issue 4, Pages 369
Publisher
MDPI AG
Online
2021-04-01
DOI
10.3390/biomedicines9040369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High Efficacy by GAL-021: A Known Intravenous Peripheral Chemoreceptor Modulator that Suppresses BKCa-Channel Activity and Inhibits IK(M) or Ih
- (2020) Te-Ling Lu et al. Biomolecules
- Brivaracetam prevents the over-expression of synaptic vesicle protein 2A and rescues the deficits of hippocampal Long-term potentiation in vivo in chronic temporal lobe epilepsy rats
- (2020) Yu-Xing Ge et al. CURRENT NEUROVASCULAR RESEARCH
- Brivaracetam efficacy and tolerability in clinical practice: A UK-based retrospective multicenter service evaluation
- (2020) J. Adewusi et al. EPILEPSY & BEHAVIOR
- Inhibitory Effective Perturbations of Cilobradine (DK-AH269), A Blocker of HCN Channels, on the Amplitude and Gating of Both Hyperpolarization-Activated Cation and Delayed-Rectifier Potassium Currents
- (2020) Te-Ling Lu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Efficacy and tolerability of intravenous brivaracetam for status epilepticus: A systematic review
- (2020) Kevin Michael C. Moalong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Evidence for the Effectiveness of Remdesivir (GS-5734), a Nucleoside-Analog Antiviral Drug in the Inhibition of IK(M) or IK(DR) and in the Stimulation of IMEP
- (2020) Wei-Ting Chang et al. Frontiers in Pharmacology
- Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
- (2020) Ronald C. Reed et al. CNS DRUGS
- Telmisartan, an Antagonist of Angiotensin II Receptors, Accentuates Voltage-Gated Na+ Currents and Hippocampal Neuronal Excitability
- (2020) Ming-Chi Lai et al. Frontiers in Neuroscience
- The Protective Role of Peroxisome Proliferator-Activated Receptor-Gamma in Seizure and Neuronal Excitotoxicity
- (2019) Te-Yu Hung et al. MOLECULAR NEUROBIOLOGY
- Use of Newer Anticonvulsants for the Treatment of Status Epilepticus
- (2019) Salia Farrokh et al. PHARMACOTHERAPY
- Brivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities
- (2019) Evangelia Theochari et al. EPILEPSY & BEHAVIOR
- Neural Networks in Generalized Epilepsy and Novel Antiepileptic Drugs
- (2019) Felix-Martin Werner et al. CURRENT PHARMACEUTICAL DESIGN
- Brivaracetam for epilepsy
- (2019) Van Hellerslia et al. JAAPA-Journal of the American Academy of Physician Assistants
- Intravenous Brivaracetam in the Treatment of Status Epilepticus: A Systematic Review
- (2019) Francesco Brigo et al. CNS DRUGS
- Effects of cannabidiol on brivaracetam plasma levels
- (2019) Kerstin A. Klotz et al. EPILEPSIA
- Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus
- (2019) Laurent Maximilian Willems et al. EXPERT OPINION ON PHARMACOTHERAPY
- Brivaracetam efficacy and safety in focal epilepsy
- (2019) Yamane Makke et al. Expert Review of Neurotherapeutics
- Effect of brivaracetam on the anger levels of epilepsy patients. A prospective open-labelled controlled study
- (2019) Manuel Toledo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients
- (2019) Edwin Liu et al. PEDIATRIC DRUGS
- Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience
- (2019) Sara McGuire et al. JOURNAL OF CHILD NEUROLOGY
- The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents
- (2019) Lai et al. Biomolecules
- Economic Value of Adjunctive Brivaracetam Treatment Strategy for Focal Onset Seizures in Finland
- (2019) Saku Väätäinen et al. ADVANCES IN THERAPY
- Treatment with brivaracetam in children – The experience of a pediatric epilepsy center
- (2019) Andreea Nissenkorn et al. EPILEPSY & BEHAVIOR
- Efficacy, retention, and safety of brivaracetam in adult patients with genetic generalized epilepsy
- (2019) Elena Fonseca et al. EPILEPSY & BEHAVIOR
- Multiple regulatory actions of 2-guanidine-4-methylquinazoline (GMQ), an agonist of acid-sensing ion channel type 3, on ionic currents in pituitary GH 3 cells and in olfactory sensory (Rolf B1.T) neurons
- (2018) Edmund Cheung So et al. BIOCHEMICAL PHARMACOLOGY
- Multiple Actions of Rotenone, an Inhibitor of Mitochondrial Respiratory Chain, on Ionic Currents and Miniature End-Plate Potential in Mouse Hippocampal (mHippoE-14) Neurons
- (2018) Chin-Wei Huang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Use of brivaracetam in genetic generalized epilepsies and for acute, intravenous treatment of absence status epilepticus
- (2018) Adam Strzelczyk et al. EPILEPSIA
- Evidence of Decreased Activity in Intermediate-Conductance Calcium-Activated Potassium Channels During Retinoic Acid–Induced Differentiation in Motor Neuron–Like NSC-34 Cells
- (2018) Pei-Chun Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Novel drugs and early polypharmacotherapy in status epilepticus
- (2018) Marta Amengual-Gual et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice
- (2018) Vicente Villanueva et al. ACTA NEUROLOGICA SCANDINAVICA
- Postmarketing experience with brivaracetam in the treatment of focal epilepsy in children and adolescents
- (2018) Susanne Schubert-Bast et al. EPILEPSY & BEHAVIOR
- Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model
- (2018) Itzel Jatziri Contreras-García et al. EPILEPSY & BEHAVIOR
- Intravenous brivaracetam in status epilepticus: Correlation between loading dose, plasma levels and clinical response
- (2018) Irene Aicua-Rapun et al. EPILEPSY RESEARCH
- Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons
- (2017) Isabelle Niespodziany et al. EPILEPSIA
- Evaluation of brivaracetam efficacy as monotherapy in adult patients with focal seizures
- (2017) Rik Schoemaker et al. EPILEPSY RESEARCH
- Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
- (2017) Rik Schoemaker et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Evaluation of brivaracetam: a new drug to treat epilepsy
- (2017) Jasmina R. Milovanović et al. EXPERT OPINION ON PHARMACOTHERAPY
- Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures
- (2017) John A. Kappes et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells
- (2017) Ambra Rizzo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- New developments in the management of partial-onset epilepsy: role of brivaracetam
- (2017) Giangennaro Coppola et al. Drug Design Development and Therapy
- Brivaracetam: a novel antiepileptic drug for focal-onset seizures
- (2017) Linda J. Stephen et al. Therapeutic Advances in Neurological Disorders
- A New SV2A Ligand for Epilepsy
- (2016) Michael A. Rogawski CELL
- Brivaracetam: A Review in Partial-Onset (Focal) Seizures in Patients with Epilepsy
- (2016) Sheridan M. Hoy CNS DRUGS
- Brivaracetam: First Global Approval
- (2016) Anthony Markham DRUGS
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Brivaracetam for the treatment of epilepsy
- (2016) Pavel Klein et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs
- (2016) Francesco Brigo et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Brivaracetam in the treatment of focal and idiopathic generalized epilepsies and of status epilepticus
- (2016) Adam Strzelczyk et al. Expert Review of Clinical Pharmacology
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam augments short-term depression and slows vesicle recycling
- (2015) Xiaofeng Yang et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons
- (2014) Isabelle Niespodziany et al. CNS Neuroscience & Therapeutics
- Reliability of spike and burst firing in thalamocortical relay cells
- (2013) Fleur Zeldenrust et al. JOURNAL OF COMPUTATIONAL NEUROSCIENCE
- Estrogen receptor alpha and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models
- (2010) S. Gingerich et al. NEUROSCIENCE
- Analytical studies of rapidly inactivating and noninactivating sodium currents in differentiated NG108-15 neuronal cells
- (2009) Sheng-Nan Wu et al. JOURNAL OF THEORETICAL BIOLOGY
- Underlying mechanism of actions of tefluthrin, a pyrethroid insecticide, on voltage-gated ion currents and on action currents in pituitary tumor (GH3) cells and GnRH-secreting (GT1-7) neurons
- (2009) Sheng-Nan Wu et al. TOXICOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- New molecular targets for antiepileptic drugs: α2δ, SV2A, and Kv7/KCNQ/M potassium channels
- (2008) Michael A. Rogawski et al. Current Neurology and Neuroscience Reports
- Brivaracetam: a new drug in development for epilepsy and neuropathic pain
- (2008) Barbara Malawska et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Tramadol-induced block of hyperpolarization-activated cation current in rat pituitary lactotrophs
- (2008) Yen-Chin Liu et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started